Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06609941
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-09-20
Brief Title:
Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Additive Effects of Alternative Nostril Breathing with Pharmacological Management on Dyspnea and Control Pause in Patients with Bronchial Asthma
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Bronchial asthma is a widespread chronic condition charactrized by inflammation and narrowing of airways leading to repeateted episodes of breathlessness wheezing and labored breathingBreathing exercises help to manage hyperventilation often seen in asthmatic patients To handle respiratory complications asthmatics are advised to practise nasal breathing techniques in conjunction with their prescribed medications
Detailed Description:
Bronchial asthma is a very common chronic disease marked by inflammation and constriction of airways resulting in recurrent episodes of breathlessness wheezing and decrease work of breathing Breathing exercises help to manage hyperventilation associated with asthma In order to manage respiratory conditions asthmatic patients are encouraged for nasal breathing techniques along with pharmacological management Hence the objective of the study is to compare the effects of alternative nostril breathing along with pharmacological management versus pharmacological management alone on dyspnea control pause asthma control and peak expiratory flow rate in patients with bronchial asthma
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None